NOVAVIDO IS BORN, THE START-UP THAT WILL STUDY THE FIRST ARTIFICIAL LIQUID RETINA ON HUMANS
Alfasigma, Utopia SIS, David Chiossone Institute and Club2021 will invest 6 million euros with two rounds of seeding to initiate the final clinical phase of experimentation of this possible solution f...
Read more